Illimis Therapeutics
- Biotech or pharma, therapeutic R&D
Ilimis Therapeutics is a platform-based Korean biotech company developing a chimeric fusion protein platform for Neurodegenerative/Immune diseases. Our platform is differentiated by its ability to address the concern of antibody-induced neuroinflammation.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}